Dr. Eric Lawitz, clinical professor of medicine in the Division of Gastroenterology, is featured in this Q&A about a new drug being evaluated for nonalcoholic steatohepatitis. Dr. Lawitz led the phase 2 study with promising results.
Newsroom
Dr. Eric Lawitz, clinical professor of medicine in the Division of Gastroenterology, is featured in this Q&A about a new drug being evaluated for nonalcoholic steatohepatitis. Dr. Lawitz led the phase 2 study with promising results.